International Flavors & Fragrances EBITDA Margin 2010-2024 | IFF
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for International Flavors & Fragrances (IFF) over the last 10 years. The current EBITDA margin for International Flavors & Fragrances as of September 30, 2024 is .
| International Flavors & Fragrances EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-09-30 |
$11.42B |
$-0.84B |
-7.34% |
| 2024-06-30 |
$11.31B |
$-0.89B |
-7.89% |
| 2024-03-31 |
$11.35B |
$-0.90B |
-7.91% |
| 2023-12-31 |
$11.48B |
$-0.97B |
-8.43% |
| 2023-09-30 |
$11.62B |
$1.67B |
14.35% |
| 2023-06-30 |
$11.86B |
$-0.47B |
-3.93% |
| 2023-03-31 |
$12.24B |
$-0.38B |
-3.14% |
| 2022-12-31 |
$12.44B |
$-0.15B |
-1.18% |
| 2022-09-30 |
$12.63B |
$-0.07B |
-0.52% |
| 2022-06-30 |
$12.64B |
$2.22B |
17.58% |
| 2022-03-31 |
$12.42B |
$2.14B |
17.23% |
| 2021-12-31 |
$11.66B |
$1.74B |
14.94% |
| 2021-09-30 |
$9.90B |
$1.45B |
14.69% |
| 2021-06-30 |
$8.09B |
$1.09B |
13.49% |
| 2021-03-31 |
$6.20B |
$0.86B |
13.87% |
| 2020-12-31 |
$5.08B |
$0.89B |
17.53% |
| 2020-09-30 |
$5.10B |
$0.91B |
17.93% |
| 2020-06-30 |
$5.10B |
$0.95B |
18.56% |
| 2020-03-31 |
$5.19B |
$1.02B |
19.63% |
| 2019-12-31 |
$5.14B |
$0.99B |
19.22% |
| 2019-09-30 |
$5.08B |
$0.96B |
18.86% |
| 2019-06-30 |
$4.72B |
$0.88B |
18.70% |
| 2019-03-31 |
$4.34B |
$0.80B |
18.30% |
| 2018-12-31 |
$3.98B |
$0.76B |
19.03% |
| 2018-09-30 |
$3.61B |
$0.74B |
20.42% |
| 2018-06-30 |
$3.58B |
$0.73B |
20.31% |
| 2018-03-31 |
$3.50B |
$0.72B |
20.62% |
| 2017-12-31 |
$3.40B |
$0.67B |
19.74% |
| 2017-09-30 |
$3.31B |
$0.64B |
19.29% |
| 2017-06-30 |
$3.21B |
$0.61B |
18.97% |
| 2017-03-31 |
$3.16B |
$0.62B |
19.49% |
| 2016-12-31 |
$3.12B |
$0.66B |
21.05% |
| 2016-09-30 |
$3.07B |
$0.68B |
22.19% |
| 2016-06-30 |
$3.06B |
$0.71B |
23.29% |
| 2016-03-31 |
$3.03B |
$0.69B |
22.89% |
| 2015-12-31 |
$3.02B |
$0.68B |
22.45% |
| 2015-09-30 |
$3.06B |
$0.68B |
22.32% |
| 2015-06-30 |
$3.07B |
$0.68B |
21.97% |
| 2015-03-31 |
$3.09B |
$0.68B |
22.11% |
| 2014-12-31 |
$3.09B |
$0.68B |
22.05% |
| 2014-09-30 |
$3.06B |
$0.65B |
21.16% |
| 2014-06-30 |
$3.03B |
$0.64B |
21.09% |
| 2014-03-31 |
$3.00B |
$0.62B |
20.77% |
| 2013-12-31 |
$2.95B |
$0.60B |
20.32% |
| 2013-09-30 |
$2.91B |
$0.60B |
20.73% |
| 2013-06-30 |
$2.88B |
$0.59B |
20.62% |
| 2013-03-31 |
$2.84B |
$0.58B |
20.43% |
| 2012-12-31 |
$2.82B |
$0.56B |
19.95% |
| 2012-09-30 |
$2.79B |
$0.51B |
18.31% |
| 2012-06-30 |
$2.79B |
$0.50B |
18.06% |
| 2012-03-31 |
$2.79B |
$0.49B |
17.63% |
| 2011-12-31 |
$2.79B |
$0.50B |
18.01% |
| 2011-09-30 |
$2.77B |
$0.54B |
19.39% |
| 2011-06-30 |
$2.73B |
$0.53B |
19.43% |
| 2011-03-31 |
$2.68B |
$0.52B |
19.46% |
| 2010-12-31 |
$2.62B |
$0.50B |
18.91% |
| 2010-09-30 |
$2.58B |
$0.50B |
19.43% |
| 2010-06-30 |
$2.52B |
$0.47B |
18.62% |
| 2010-03-31 |
$2.42B |
$0.44B |
18.34% |
| 2009-12-31 |
$2.33B |
$0.42B |
18.01% |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$23.219B |
$11.479B |
|
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.
|
